Annual report
4565.TEDINET S100XTYN
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 144
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.6bn | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥28.8bn | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥12.8bn | 2023-01-01 → 2023-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥15.6bn | 2022-01-01 → 2022-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥17.7bn | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | −¥8.5bn | 2025-01-01 → 2025-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥5.4bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥14.9bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥4.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥10.7bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥1.1bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥433m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | −¥12.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥4.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥7.2bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥382m | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | −¥12.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥4.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥134.8bn | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥151.5bn | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥157.2bn | at 2023-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥99.4bn | at 2022-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥97.0bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥73.8bn | at 2025-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥83.0bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥61.0bn | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥68.5bn | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥66.8bn | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥61.0bn | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥68.5bn | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥66.8bn | at 2023-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥57.9bn | at 2022-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥57.5bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥20.4bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥32.3bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥49.1bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥66.6bn | at 2022-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥60.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | −¥2.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥7.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥5.3bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥10.0bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥7.1bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | ¥5.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥63.8bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥1.0bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥278m | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥16.0bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥6.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥48.3bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥4.9bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥11.1bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥-138.8 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-53.92 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-87.18 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥4.68 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥12.53 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-138.8 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-53.92 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-87.18 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥4.63 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥12.4 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥674.04 | at 2025-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥762.15 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥746.92 | at 2023-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥707.2 | at 2022-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥704.97 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 42.5% | at 2023-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 58.3% | at 2022-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 59.3% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | -19.3% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -7.2% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -11.5% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 0.7% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 382 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 374 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 350 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 202 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 198 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥19.0bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥6.6bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥5.0bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥823m | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.6bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥4.6bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥713m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.5bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥3.3bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥4.7bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥23.7bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.2bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥23.7bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥2.1bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | −¥3.3bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.5bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥4.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥105.0bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥136.1bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥142.0bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥89.4bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥94.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥60.0bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥68.1bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥44.9bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥68.1bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥65.2bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥57.5bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥58.5bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-262.41 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.89 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.81 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.3 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-52.47 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.63 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥493.98 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥754.41 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥726.29 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥699.45 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥714.03 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.6% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.7% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.2% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 90,496,735 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 89,902,858 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 89,446,777 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 81,923,230 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 81,518,316 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 50 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 58 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 41 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 32 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 30 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,400
| Item | Context | Value | Unit |
|---|---|---|---|
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-03-25 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第36期(自 2025年１月１日 至 2025年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ネクセラファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Nxera Pharma Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表執行役社長CEO クリストファー・カーギル | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(5962)5718 (代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)チーフ・アカウンティング・オフィサー キーラン・ジョンソン | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(5962)5718 (代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)チーフ・アカウンティング・オフィサー キーラン・ジョンソン | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00981 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ネクセラファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Nxera Pharma Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2025-01-01 | |
| Current period end date | FilingDateInstant | 2025-12-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2025-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-01-01 | |
| Comparative period end date | FilingDateInstant | 2024-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |